The firm also said it had a net loss of $7.9 million, or $3.50 per share, in 2014, compared to a net loss of $2.4 million, or $12.23 per share, in 2013.
The method detected differences in the vaginal microbiome that matched up with patients' clinical diagnoses of vaginosis, and also their response to antibiotic treatment.
The company is using a $3 million, three-year grant to clinically validate the test, which it hopes will be the first of its kind approved by the FDA.
In a letter to a New York court, the investor alleged that Arrayit has failed to meet the terms of a settlement that was supposed to end litigation filed last year.
Cryoport will oversee the distribution of CombiMatrix's CombiPGS preimplantantion genetic screening test for women undergoing in vitro fertilization.
In PLOS this week: variant linked to canine cleft lip, new compression tool, and more.
GNC will start using DNA testing to authentic the presence of plants included in its labels, following an agreement with the New York Attorney General.
Fareed Zakaria writes that instead of focusing solely on STEM-related courses, students would do well to pursue the liberal arts if they want to be technology innovators.
A Harvard Business Review study found four major patterns of gender biases and added that black and Latina scientists further had to navigate racial stereotypes.